Financials

  • Market Capitalization 2.57 B
  • Employee 47
  • Founded 1998
  • CEO Helen Sabzevari
  • Website www.precigen.com
  • Headquarter Virginia, United States
  • FIGI BBG000QL8VH9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.05
Price to sales ratio
135.09

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1805
VRDN
Viridian Therapeutics, Inc. - Common Stock
23.88 USD-1.57%-3.12%+22.09%+6.37%2.71 B USD
1839
RARE
Ultragenyx Pharmaceutical Inc. - Common Stock
26.26 USD-0.68%+2.22%+1.90%-13.25%2.59 B USD
1847
TRVI
Trevi Therapeutics, Inc. - Common Stock
17.96 USD+0.22%-2.60%-2.76%+150.49%2.56 B USD
1849
NKTR
Nektar Therapeutics - Common Stock
74.55 USD+1.06%-0.73%+4.72%+1.75%2.55 B USD

Frequently asked questions about Precigen, Inc. Common Stock

What is the Precigen, Inc. Common Stock stock price today?

The current price of Precigen, Inc. Common Stock (PGEN) is 7.19. Over the past 24 hours, the stock has changed by -3.10%. Follow the PGEN chart for real-time price dynamics.

What is the stock ticker of Precigen, Inc. Common Stock?

Precigen, Inc. Common Stock trades under the ticker PGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Precigen, Inc. Common Stock stock going up?

PGEN has changed by -4.13% over the last week, +29.32% over the last month, and +59.07% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Precigen, Inc. Common Stock?

Precigen, Inc. Common Stock currently has a market capitalization of 2.57 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Precigen, Inc. Common Stock earnings last quarter?

Last quarter, Precigen, Inc. Common Stock reported earnings of 0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Precigen, Inc. Common Stock revenue for the last quarter?

Precigen, Inc. Common Stock reported quarterly revenue of 54.98 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Precigen, Inc. Common Stock net income for the last quarter?

Precigen, Inc. Common Stock reported net income of 20.07 M for the last quarter. The previous quarter showed -7.93 M, which means net income changed by +353.13%.

How many employees does Precigen, Inc. Common Stock have?

As of the latest available data, Precigen, Inc. Common Stock has 47 employees. Workforce size can provide additional context about the company's scale and operations.

What is Precigen, Inc. Common Stock EBITDA?

Precigen, Inc. Common Stock EBITDA is 23.74 M, and its EBITDA margin is 43.19%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Precigen, Inc. Common Stock stock?

You can buy Precigen, Inc. Common Stock (PGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Precigen, Inc. Common Stock stock?

Investing in Precigen, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PGEN chart and related analysis on metatrader.com as part of your research.

Precigen, Inc. - Common Stock

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

News